DePuy Orthopaedics Newswire

DePuy Orthopaedics Newswire

Comprehensive Real-Time News Feed for DePuy Orthopaedics.

Results 1 - 20 of 579 in DePuy Orthopaedics

  1. Johnson & Johnson May Already Have Its Remicade Replacement Well in HandRead the original story w/Photo

    2 hrs ago | The Motley Fool

    This drug being sold by J&J "definitely" has $9 billion in peak sales potential, according to Genmab's CEO. . Johnson & Johnson is often a staple holding for income seekers, conservative investors, and even value investors.

    Comment?

  2. Trump meets with top US manufacturersRead the original story w/Photo

    Thursday | WFFT-TV Fort Wayne

    President Trump met Thursday morning with the heads of two dozen manufacturing companies, including Dell, Ford, GE, Emerson Electric and Johnson & Johnson. Several of Trump's key economic advisers, including Treasury Secretary Steven Mnuchin and Commerce Secretary Wilbur Ross, attended event, which the White House is calling a "listening session."

    Comment?

  3. Lessons from NFL Star Charles 'Peanut' TillmanRead the original story w/Photo

    Thursday | News Times

    I recently attended and participated in the Dad 2.0 Summit in San Diego, where a collection of daddy bloggers with different perspectives came together to talk about life, career, fatherhood and a dozen other issues -- racism, sexism and homophobia; blended families and vulnerability. The entire conference was terrific, but one keynote speaker particularly touched my heart, as a father and as a professional.

    Comment?

  4. Pachira Investments Inc. Takes Position in Johnson & JohnsonRead the original story w/Photo

    Thursday | Daily Political

    Pachira Investments Inc. purchased a new stake in Johnson & Johnson during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 3,944 shares of the company's stock, valued at approximately $454,000.

    Comment?

  5. Johnson & Johnson (JNJ) is Osborn Williams & Donohoe LLC's 5th Largest PositionRead the original story w/Photo

    Wednesday Feb 22 | IntersportsWire

    Osborn Williams & Donohoe LLC reduced its position in Johnson & Johnson by 0.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 94,282 shares of the company's stock after selling 722 shares during the period.

    Comment?

  6. Hall Laurie J Trustee Acquires Shares of 52,653 Johnson & JohnsonRead the original story w/Photo

    Tuesday Feb 21 | IntersportsWire

    Hall Laurie J Trustee acquired a new stake in Johnson & Johnson during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm acquired 52,653 shares of the company's stock, valued at approximately $6,124,000.

    Comment?

  7. North America Trauma Fixation Devices Market - Opportunities and...Read the original story

    Tuesday Feb 21 | Customer Interaction Solutions

    Trauma fixation devices are used for treatment of internal injuries, such as dislocations, fractures, bruises and external injuries, burns, cuts, and others such injuries. Internal fixation devices are implanted into the body for the stabilization of severe fractures and dislocations, and deformity correction procedures.

    Comment?

  8. Ford still can repair its brand in South Africa but it needs to act quicklyRead the original story w/Photo

    Sunday Feb 19 | Bizcommunity

    There can be no doubt that the Ford Kuga brand in South Africa is in trouble following the model's propensity to burst into flames . Ford South Africa has not helped the situation with its lethargic reaction to what's now a major crisis.

    Comment?

  9. Investors Sell Shares of Johnson & Johnson (JNJ) on Strength After Insider SellingRead the original story w/Photo

    Saturday Feb 18 | Daily Political

    Investors sold shares of Johnson & Johnson on strength during trading on Thursday after an insider sold shares in the company. $116.65 million flowed into the stock on the tick-up and $256.34 million flowed out of the stock on the tick-down, for a money net flow of $139.69 million out of the stock.

    Comment?

  10. Better Buy: Eli Lilly and Company vs. Johnson & JohnsonRead the original story w/Photo

    Saturday Feb 18 | The Motley Fool

    But Lilly looks relatively small when compared to Johnson & Johnson Both of these companies' stocks have enjoyed success over the past five years. Lilly's shares jumped over 80% during the period, while Johnson & Johnson's share price more than doubled.

    Comment?

  11. 2005 bomb blasts: Court slams IO for 'shabby' probe into role of accusedRead the original story w/Photo

    Friday Feb 17 | DNA India

    The Special Cell had alleged that Dar, a medical representative with Johnson & Johnson , had received Rs 1,401,000 from another accused Ghulam Ahmad Khan through hawala, and the money was used for terror activities. The judge who set free three accused in the 2005 Sarojini Nagar market blast, which claimed 67 lives and injured more than 200, made scathing observations on Investigating Officer Sanjeev Kumar Yadav for his "lackadaisical attitude in investigating the role of accused Tariq Ahmad Dar".

    Comment?

  12. Johnson & Johnson's half-hearted switch from plastic to paper cotton buds isn't good enoughRead the original story w/Photo

    Friday Feb 17 | TreeHugger

    It's only happening in half the world. The rest of us can keep using plastic sticks.

    Comment?

  13. Johnson & Johnson (JNJ) Short Interest UpdateRead the original story w/Photo

    Wednesday Feb 15 | Daily Political

    Johnson & Johnson saw a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 15,619,549 shares, a decrease of 20.1% from the January 13th total of 19,543,330 shares.

    Comment?

  14. Sometimes history is all around usRead the original story w/Photo

    Tuesday Feb 14 | Daily Journal

    I was walking down the sidewalk between Jefferson and Monroe when my longtime buddy, Arthur, walked by. Hadn't seen him for a while.

    Comment?

  15. Global Antibodies Market Expected to Increase at a CAGR of 12.5% During Forecast Period 2016-2026Read the original story w/Photo

    Monday Feb 13 | SBWire

    High rate of product approvals, combined with rising adoption of therapeutic antibodies in developing economies is positively influencing the growth of the global antibodies market, with total revenues expected to surpass US$ 105 Bn in 2016. Approval of monoclonal antibody products, including therapeutic antibodies, drug conjugates, and antibody fragments in key markets of the U.S., Europe, and Japan have bolstered the growth of the global antibodies market.

    Comment?

  16. GlaxoSmithKline: 2016's Results Bode Very Well For The FutureRead the original story w/Photo

    Monday Feb 13 | Seeking Alpha

    All segments saw healthy growth even though pharma faces potential trouble of blockbuster Advair generic competition. GlaxoSmithKline has had an interesting few years.

    Comment?

  17. Bernstein Liebhard LLP.Read the original story w/Photo

    Monday Feb 13 | PR Newswire

    During opening statements last week, a plaintiff's attorney asserted that Johnson & Johnson's "love of money" led it to ignore a growing body of research linking the genital application of talcum powder to an increased risk of ovarian cancer. Among other things, he pointed out that the same research had caused condom manufacturers to stop using talc in the 1990s, and highlighted an internal Johnson & Johnson document which warned that ignoring studies linking talc to ovarian cancer could cause the public to perceive the company "like it perceives the cigarette industry."

    Comment?

  18. Johnson & Johnson (JNJ) Position Lowered by Cullen Capital Management LLCRead the original story w/Photo

    Monday Feb 13 | IntersportsWire

    Cullen Capital Management LLC lowered its stake in shares of Johnson & Johnson by 4.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 793,705 shares of the company's stock after selling 34,040 shares during the period.

    Comment?

  19. Compagnie Lombard Odier SCmA Sells 33,431 Shares of Johnson & JohnsonRead the original story w/Photo

    Friday Feb 10 | IntersportsWire

    Compagnie Lombard Odier SCmA decreased its position in shares of Johnson & Johnson by 10.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 297,778 shares of the company's stock after selling 33,431 shares during the period.

    Comment?

  20. UPDATE 1-EMA panel says that use of Actelion's Uptravi may continueRead the original story w/Photo

    Friday Feb 10 | Reuters

    Feb 10 A European Medicines Agency drug safety panel recommended on Friday that Actelion's Uptravi drug may continue to be used amid a probe into five deaths in France among those using the pulmonary arterial hypertension medicine. Shares in the Swiss drugmaker, which is being bought for $30 billion by Johnson & Johnson, rose more than 3 percent by 1340 GMT.

    Comment?